Karnataka Passes Key Amendment to Drugs and Cosmetics Act
Karnataka Assembly passes the Drugs and Cosmetics (Amendment) Bill, 2024, enhancing penalties for spurious drug manufacturers and regulating online pharmacy sales. Learn the key changes.
Category : Search result: generic drugs opportunity
Karnataka to appeal HC order on Jan Aushadi Kendras closure
Karnataka Health Minister Dinesh Gundu Rao announces state will appeal HC order quashing closure of Jan Aushadi Kendras in govt hospitals. Read the full story.
Shark Tank's Mittal on Ozempic Launch & 2026 Pharma Shift
Shark Tank India's Anupam Mittal comments on Ozempic's India launch, its ₹8,800/month price, and the 2026 patent expiry that could 5x the market. Read his take on fitness shortcuts vs. discipline.
Delhi seals shop, seizes 204 drug samples in Bhagirath Palace raid
Delhi's Drugs Control department sealed a shop & collected 204 samples from 27 wholesale dealers in a major drive against illegal drug trade. Health Minister vows zero tolerance for spurious medicines.
Court Rejects Ozempic Patent Extension, Boosts Generic Drug Access
Delhi High Court rejects Novo Nordisk's patent plea on semaglutide (Ozempic/Wegovy), preventing 'evergreening'. A win for affordable generics in India, but raises concerns over non-clinical misuse of weight-loss drugs. Read more.
Dr Reddy's Wins Delhi HC Nod to Export Semaglutide
Delhi High Court permits Dr Reddy's to export generic semaglutide, a major win for Indian drugmakers eyeing the booming anti-obesity market. Read the full analysis.
6 Habits of People Who Naturally Attract Good Luck
Discover the six subtle, daily habits that create a 'soft tailwind' of luck. Learn how openness, kindness, and micro-wins build a life where opportunities flow naturally.
Indian Companies Set for Semaglutide Device Windfall
Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.
Govt Plans Ban on Online Ads for High-Risk Drugs
Indian government proposes sweeping ban on online advertisements for Schedule G, H, H1, and X drugs to combat self-medication and antimicrobial resistance. Read about the new regulatory changes.
Orry Seeks New Date in Mumbai Police Drug Case
Mumbai Police summons socialite Orry in Rs 252 crore drug case. He seeks new date citing prior commitments. Investigation continues in high-profile narcotics bust.
Orry summoned by Mumbai Police in drugs case
Social media influencer Orry faces Mumbai Police questioning in massive Rs 252 crore mephedrone drug bust case uncovered in Sangli. Latest developments.
Novo Nordisk brings back former CEO as chairman
Lars Rebien Sorensen returns as Novo Nordisk chairman after board shakeup. The move follows Pfizer's $10B Metsera acquisition, intensifying obesity drug competition.
Bittu Urges Support for Chitta-Free Himachal Campaign
Union Minister Bittu appeals to Himachal residents to support anti-drug campaign. Learn how communities can fight drug menace together for a safer state.
Nagaland DGP: Drug crisis threatens public health emergency
Nagaland's top police official warns drug menace could become public health emergency, calls for unified Northeast response. Golden Triangle proximity cited as major concern.
Mahindra-Manulife Launch Life Insurance Joint Venture
Mahindra Group partners with Manulife Financial to create 50:50 life insurance JV, targeting India's growing rural market. Read about this strategic partnership.
OneSource Pharma Raises FY28 Revenue Target to $500M
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Biocon Banks on Weight-Loss Drugs, Ups Biosimilar Stake
Biocon's generics business surges 24% driven by weight-loss drugs liraglutide & semaglutide. CEO Siddharth Mittal reveals strategy to capture share of the booming $95 billion GLP-1 market.
Novo Nordisk cuts Wegovy price 37% in India
Novo Nordisk reduces Wegovy's price by 37% in India as it faces patent loss and competition from Eli Lilly's Mounjaro and upcoming generic versions. Discover the new costs.
Medicare Deal Slashes Obesity Drug Prices for Millions
Trump administration secures obesity drug price cuts with Eli Lilly and Novo Nordisk. Medicare coverage expansion opens 30 million patient market starting April 2026. Read analysis.
Where Bengaluru's Seized Drugs Actually Go
Exclusive investigation reveals the secret journey of confiscated drugs in India's tech capital - from police vaults to scientific destruction methods that prevent environmental damage.
Trump: Deal Reached to Lower Weight Loss Drug Prices
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
White House Deal Cuts Ozempic & Wegovy Prices in India
In a major breakthrough for weight management, the White House has secured a deal that significantly reduces prices of popular drugs Ozempic and Wegovy, making effective weight loss treatment more accessible across India.
Big Pharma Cuts Obesity Drug Prices After Trump Pressure
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
₹6.2Cr Yaba Drug Bust in Assam: Two Nabbed
In a major crackdown on drug trafficking, Assam Police intercepts huge consignment of illegal Yaba tablets in Cachar district, arresting two key suspects in coordinated operation.
Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Rahul Gandhi: Instagram Reels are Digital Drugs
Congress leader Rahul Gandhi launches scathing attack on PM Modi, comparing Instagram Reels to digital drugs and criticizing cheap data policies for creating addiction among Indian youth.
Obesity Drugs: Not Miracle Cures
Discover why revolutionary weight-loss drugs aren't magic bullets for India's obesity crisis. Learn about limitations, costs, and sustainable solutions.
Novo Nordisk Profit Drops 27%, Cuts 9,000 Jobs
Danish pharmaceutical giant Novo Nordisk faces turbulent times as Q3 profits drop 27% despite Ozempic's success. The company announces massive restructuring with 9,000 job cuts worldwide. Get the inside story on what's happening behind the scenes.
Chatra Police Bust Opium Ring, Seize 2.8 Kg Drugs
In a significant crackdown, Chatra police arrested five suspects involved in interstate opium smuggling and confiscated narcotics worth lakhs in international market.
Page 2 of 4